Millennium Management — REGN Trade History
Quarter-by-quarter changes in the REGENERON PHARMACEUTICALS position · CUSIP 75886F107
Currently held · 9.3 YearsFirst seen: 2016 Q3
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-14 | Add | 165,120 | 102,390 | +163.2% | $103.0M | 0.04% |
| 2026 Q1 | 2026-05-15 | Reduce | 62,730 | -317,038 | -83.5% | $48.5M | 0.02% |
| 2025 Q4 | 2026-02-17 | Add | 379,768 | 178,688 | +88.9% | $293.1M | 0.12% |
| 2025 Q3 | 2025-11-14 | Reduce | 201,080 | -137,746 | -40.7% | $113.1M | 0.05% |
| 2025 Q2 | 2025-08-14 | Add | 338,826 | 169,241 | +99.8% | $177.9M | 0.09% |
| 2025 Q1 | 2025-05-15 | Add | 169,585 | 36,078 | +27.0% | $107.6M | 0.06% |
| 2024 Q4 | 2025-02-14 | Reduce | 133,507 | -67,667 | -33.6% | $95.1M | 0.05% |
| 2024 Q3 | 2024-11-14 | Reduce | 201,174 | -65,858 | -24.7% | $211.5M | 0.10% |
| 2024 Q2 | 2024-08-14 | Add | 267,032 | 67,826 | +34.0% | $280.7M | 0.13% |
| 2024 Q1 | 2024-05-15 | Reduce | 199,206 | -81,075 | -28.9% | $191.7M | 0.08% |
| 2023 Q4 | 2024-02-14 | Add | 280,281 | 243,272 | +657.3% | $246.2M | 0.11% |
| 2023 Q3 | 2023-11-14 | Reduce | 37,009 | -12,650 | -25.5% | $30.5M | 0.01% |
| 2023 Q2 | 2023-08-14 | Reduce | 49,659 | -226,914 | -82.0% | $35.7M | 0.02% |
| 2023 Q1 | 2023-05-15 | Add | 276,573 | 242,590 | +713.9% | $227.3K | 0.13% |
| 2022 Q4 | 2023-02-14 | Add | 33,983 | 22,876 | +206.0% | $24.5K | 0.01% |
| 2022 Q3 | 2022-11-14 | Add | 11,107 | 4,906 | +79.1% | $7.7M | 0.01% |
| 2022 Q2 | 2022-08-15 | Reduce | 6,201 | -22,484 | -78.4% | $3.7M | 0.00% |
| 2022 Q1 | 2022-05-16 | Reduce | 28,685 | -96,109 | -77.0% | $20.0M | 0.01% |
| 2021 Q4 | 2022-02-14 | Add | 124,794 | 55,338 | +79.7% | $78.8M | 0.04% |
| 2021 Q3 | 2021-11-15 | Reduce | 69,456 | -115,035 | -62.4% | $42.0M | 0.03% |
| 2021 Q2 | 2021-08-16 | Reduce | 184,491 | -5,091 | -2.7% | $103.0M | 0.06% |
| 2021 Q1 | 2021-05-17 | Add | 189,582 | 4,803 | +2.6% | $89.7M | 0.06% |
| 2020 Q4 | 2021-02-16 | Add | 184,779 | 171,745 | +1317.7% | $89.3M | 0.06% |
| 2020 Q3 | 2020-11-16 | Add | 13,034 | 7,588 | +139.3% | $7.3M | 0.01% |
| 2020 Q2 | 2020-08-14 | Reduce | 5,446 | -87,934 | -94.2% | $3.4M | 0.01% |
| 2020 Q1 | 2020-05-14 | Reduce | 93,380 | -5,426 | -5.5% | $45.6M | 0.10% |
| 2019 Q4 | 2020-02-14 | Reduce | 98,806 | -246,382 | -71.4% | $37.1M | 0.05% |
| 2019 Q3 | 2019-11-14 | Reduce | 345,188 | -128,130 | -27.1% | $95.8M | 0.15% |
| 2019 Q2 | 2019-08-15 | Add | 473,318 | 439,550 | +1301.7% | $148.1M | 0.22% |
| 2019 Q1 | 2019-05-14 | Add | 33,768 | 16,033 | +90.4% | $13.9M | 0.02% |
| 2018 Q4 | 2019-02-15 | Reduce | 17,735 | -87,854 | -83.2% | $6.6M | 0.01% |
| 2018 Q3 | 2018-11-14 | Add | 105,589 | 32,674 | +44.8% | $42.7M | 0.05% |
| 2018 Q2 | 2018-08-14 | Reduce | 72,915 | -129,431 | -64.0% | $25.2M | 0.03% |
| 2018 Q1 | 2018-05-15 | Reduce | 202,346 | -275,898 | -57.7% | $69.7M | 0.09% |
| 2017 Q4 | 2018-02-14 | Add | 478,244 | 276,154 | +136.6% | $179.8M | 0.25% |
| 2017 Q3 | 2017-11-14 | Add | 202,090 | 189,365 | +1488.1% | $90.4M | 0.14% |
| 2017 Q2 | 2017-08-14 | New | 12,725 | 12,725 | — | $6.3M | 0.01% |
| 2017 Q1 | 2017-05-15 | Sold out | — | -85,875 | -100.0% | — | — |
| 2016 Q4 | 2017-02-14 | Add | 85,875 | 77,010 | +868.7% | $31.5M | 0.07% |
| 2016 Q3 | 2016-11-14 | New | 8,865 | 8,865 | — | $3.6M | 0.01% |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.